Laboratory Viollier Extends the Bus. Relationship with Bruker Concerning MALDI Biotyper System for Mass Spectrometry-based Mi...
27 June 2011 - 3:00PM
Business Wire
At the 4th Congress of European Microbiologists (Federation of
European Microbiological Societies, or FEMS), Bruker announces the
extension of its agreement with the private diagnostic laboratory
Viollier AG (www.viollier.ch), one of the leading Swiss diagnostic
laboratories, located in Basel. Viollier has used Bruker´s MALDI
Biotyper system for MALDI-TOF mass spectrometry-based microbial
identification now for more than two years and is fully satisfied
with the analytical performance of the MALDI Biotyper and
with the Bruker´s service and support infrastructure.
Since being introduced at the Viollier laboratory, the MALDI
Biotyper has become an essential part of the laboratory’s high
quality diagnostics efforts. The Viollier laboratory is committed
to cutting-edge diagnostic tools and the MALDI Biotyper
allows Viollier to provide fast and accurate microorganisms
identification results for their clients. Bruker's Open
Microbiology Concept enables the Viollier laboratory to decide for
the most suitable integration and best performing interfacing
solutions according to their requirements.
Dr. med. Olivier Dubuis at Laboratory Viollier, commented:
“Bruker is a leading supplier of MALDI-TOF mass spectrometry-based
identification systems with a very reliable support and service
network, and thus Bruker is our reliable long-term partner we were
looking for. In order to stay competitive, today’s labs have to
investigate new diagnostics solutions continuously in order to
provide high-quality but also cost-effective diagnosis. Using the
MALDI Biotyper system now for more than two years in our
daily routine, it was no question to continue the relationship with
Bruker. In our view, Bruker´s MALDI Biotyper system offers a
very reliable and smooth identification workflow that allows for a
high sample throughput and smart workflow in combination with a
superior quality level.”
Dr. Guido Mix, Director of Microbiology Sales at Bruker
Daltonics, added: “This extension of our business relationship with
Viollier AG is a major step, demonstrating that Bruker is a
reliable long-term partner for leading diagnostic laboratories.
Continuously improving the service and support capabilities as well
as continuous further developments in the fields of hardware,
software, algorithms, reference libraries and special workflows
underpins our market leading position with approximately 300
dedicated MALDI Biotyper systems installed in microbiology
laboratories worldwide.”
About the Bruker MALDI Biotyper
Bruker’s dedicated MALDI Biotyper solution enables
molecular identification, taxonomical classification or
dereplication of microorganisms like bacteria, yeasts and fungi.
Classification and identification of microorganisms is achieved
reliably and quickly using proteomic fingerprinting by
high-throughput MALDI-TOF mass spectrometry. Applications include
clinical routine microbial identification, environmental and
pharmaceutical analysis, taxonomical research, food and consumer
product processing and quality control, as well as marine
microbiology. Bruker’s robust MALDI Biotyper method requires
minimal sample preparation efforts and offers low consumables cost
per sample. The MALDI Biotyper is available in a
research-use-only version, as well as in an IVD-CE version
according to EU directive EC/98/79 in certain European countries.
For more information, please visit www.maldibiotyper.com.
For more information about Bruker Daltonics and Bruker
Corporation (NASDAQ: BRKR), please visit www.bdal.com and
www.bruker.com.
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024